Palatin Technologies Inc./$PTN
1D1W1MYTD1Y5YMAX
Capital at risk
About Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
- Ticker
- $PTN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 29
- Headquarters
- Monmouth Junction, United States
- Website
- palatin.com
PTN Metrics
BasicAdvanced
$18M
-
-$3.04
-0.11
-
Price and volume
Market cap
$18M
Beta
-0.11
52-week high
$31.00
52-week low
$7.21
Average daily volume
110K
Financial strength
Current ratio
5.041
Quick ratio
4.861
Long term debt to equity
0.009
Total debt to equity
0.027
Interest coverage (TTM)
-1,220.01%
Profitability
EBITDA (TTM)
-8.752
Gross margin (TTM)
4.28%
Net profit margin (TTM)
-48.50%
Operating margin (TTM)
-68.70%
Revenue per employee (TTM)
$440,000
Management effectiveness
Return on assets (TTM)
-65.26%
Return on equity (TTM)
-297.24%
Valuation
Price to revenue (TTM)
1.507
Price to book
1.71
Price to tangible book (TTM)
1.71
Price to free cash flow (TTM)
-1.296
Free cash flow yield (TTM)
-77.17%
Free cash flow per share (TTM)
-7.3
Growth
Revenue change (TTM)
3,581.22%
Earnings per share change (TTM)
-94.55%
3-year revenue growth (CAGR)
49.42%
3-year earnings per share growth (CAGR)
-71.42%
10-year earnings per share growth (CAGR)
-43.55%
Upcoming events
No upcoming events
PTN News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.